BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22671537)

  • 1. Bone mass and biochemical markers of bone turnover in children and adolescents with chronic immune thrombocytopenia: relation to corticosteroid therapy and vitamin D receptor gene polymorphisms.
    Tantawy AA; El Bostany EA; Matter RM; El Ghoroury EA; Ragab S; El Sherif NH
    Platelets; 2013; 24(4):282-7. PubMed ID: 22671537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late side effects of high-dose steroid therapy on skeletal system in children with idiopathic thrombocytopenic purpura.
    Yildirim ZK; Büyükavci M; Eren S; Orbak Z; Sahin A; Karakelleoğlu C
    J Pediatr Hematol Oncol; 2008 Oct; 30(10):749-53. PubMed ID: 19011472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.
    Harel Z; Gold M; Cromer B; Bruner A; Stager M; Bachrach L; Wolter K; Reid C; Hertweck P; Nelson A; Nelson D; Coupey S; Johnson C; Burkman R; Bone H
    J Adolesc Health; 2007 Jan; 40(1):44-53. PubMed ID: 17185205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced bone mineral density in childhood chronic idiopathic thrombocytopenic purpura treated with high-dose methylprednisolone.
    Dilber C; Dagdemir A; Albayrak D; Albayrak S; Kalayci AG; Aliyazicioglu Y; Basoglu T
    Bone; 2004 Jul; 35(1):306-11. PubMed ID: 15207771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor gene, biochemical bone markers and bone mineral density in Mexican women on dialysis.
    Avila M; Prado C; Ventura MD; Mora C; Briones D; Valdez H; Hurtado ME; Lindholm B; Qureshi A; Castillo-Henkel C; Paniagua R
    Nephrol Dial Transplant; 2010 Jul; 25(7):2259-65. PubMed ID: 20124547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: interaction with age, dietary calcium, and 3'-end region polymorphisms.
    Ferrari S; Rizzoli R; Manen D; Slosman D; Bonjour JP
    J Bone Miner Res; 1998 Jun; 13(6):925-30. PubMed ID: 9626623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor start codon polymorphism ( FokI) is related to bone mineral density in healthy adolescent boys.
    Strandberg S; Nordström P; Lorentzon R; Lorentzon M
    J Bone Miner Metab; 2003; 21(2):109-13. PubMed ID: 12601576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia.
    Dresner Pollack R; Rachmilewitz E; Blumenfeld A; Idelson M; Goldfarb AW
    Br J Haematol; 2000 Dec; 111(3):902-7. PubMed ID: 11122154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: the OFELY Study.
    Garnero P; Borel O; Sornay-Rendu E; Arlot ME; Delmas PD
    J Bone Miner Res; 1996 Jun; 11(6):827-34. PubMed ID: 8725180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density, body height, and vitamin D receptor gene polymorphism in middle-aged men.
    Remes T; Väisänen SB; Mahonen A; Huuskonen J; Kröger H; Jurvelin JS; Rauramaa R
    Ann Med; 2005; 37(5):383-92. PubMed ID: 16179274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures.
    Mitra D; Elvins DM; Collins AJ
    J Rheumatol; 1999 Oct; 26(10):2201-4. PubMed ID: 10529140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN; Kandemir N
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy.
    Avgeri M; Papadopoulou A; Platokouki H; Douros K; Rammos S; Nicolaidou P; Aronis S
    J Pediatr Hematol Oncol; 2008 Aug; 30(8):592-7. PubMed ID: 18799935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is bone turnover a determinant of bone mass in rheumatoid arthritis?
    Cortet B; Flipo RM; Pigny P; Duquesnoy B; Boersma A; Marchandise X; Delcambre B
    J Rheumatol; 1998 Dec; 25(12):2339-44. PubMed ID: 9858427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D receptor polymorphisms, bone mineral density, and bone metabolism in postmenopausal Mexican-American women.
    McClure L; Eccleshall TR; Gross C; Villa ML; Lin N; Ramaswamy V; Kohlmeier L; Kelsey JL; Marcus R; Feldman D
    J Bone Miner Res; 1997 Feb; 12(2):234-40. PubMed ID: 9041055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women.
    Tokita A; Matsumoto H; Morrison NA; Tawa T; Miura Y; Fukamauchi K; Mitsuhashi N; Irimoto M; Yamamori S; Miura M; Watanabe T; Kuwabara Y; Yabuta K; Eisman JA
    J Bone Miner Res; 1996 Jul; 11(7):1003-9. PubMed ID: 8797122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alterations in bone mineral metabolism in patients with calcium kidney stone disease and polymorphism of vitamin D receptor. Preliminary results].
    Moyano MJ; Gómez de Tejada MJ; García Lozano R; Moruno R; Ortega R; Martí V; Sánchez Palencia R; Miranda MJ; Palma A; Pérez Cano R
    Nefrologia; 2007; 27(6):694-703. PubMed ID: 18336098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort.
    Rubin LA; Hawker GA; Peltekova VD; Fielding LJ; Ridout R; Cole DE
    J Bone Miner Res; 1999 Apr; 14(4):633-43. PubMed ID: 10234586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.